Delivery Order SPE2DB22D2206-SPE2DB25FGL12
Award Date
4/7/25
Potential Completion Date
4/8/25
Potential Value
$21K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,553.36, is for the delivery of FULPHILA 6 MG/0.6 ML SYRINGE 0.6ML, a pharmaceutical product, with a performance period through March 25, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FULPHILA 6 MG/0.6 ML SYRINGE 0.6ML, a medical supply item. The contract has a ceiling value of $10,523.70 and is a firm fixed price type contract with a period of performance through May 19, 2025. This delivery order is part of a larger Indefinite Delivery Contract...
This is a $15,792.72 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FULPHILA 6 MG/0.6 ML SYRINGE 0.6ML, a medical product likely used in military healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fulphila 6 mg/0.6 ml syringes. The contract has a firm fixed price of $1,006.88 and a completion date of June 5, 2025. This contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fulphila 6 mg/0.6 mL syringes. The contract does not have a set-aside designation and has a ceiling value of $6,555.80. It is a firm fixed-price contract with an ultimate completion date of September 19, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
This federal contract award to AmerisourceBergen Drug Corp. is a delivery order worth $19,906.45 for the pharmaceutical product FULPHILA 6 MG/0.6 ML SYRINGE 0.6ML. The award was made by the Defense Logistics Agency (DLA), a defense agency, with a period of performance through July 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Fulphila 6 mg/0.6 mL syringes. The $11,674.80 firm fixed-price delivery order has a completion date of November 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a range of pharmaceutical products and medical supplies to...
This federal contract award is for the delivery of 4563635859 ! FULPHILA 6 MG/0.6 ML SYRINGE 0.6ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $21,740.23 and a period of performance ending on February 13, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. The award is not designated with a set-aside....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fulphila (pegfilgrastim-jmdb) 6 mg/0.6 mL syringes, a medication used to treat low white blood cell counts in patients receiving chemotherapy. The contract has a ceiling value of $6,314.22 and is a firm fixed-price delivery order, with a performance period through May 12, 2025. The...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Fulvestrant 250 mg/5 ml syringes, with a ceiling value of $1,833.12 and a period of performance through May 8, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...